• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Kids' Cancer-Drug Shortage Averted

Article

The federal Food and Drug Administration (FDA) says it managed to avert a “crisis” for kids with cancer by preventing a looming shortage of the lifesaving drug methotrexate, a mainstay of treatment for a type of childhood leukemia.

The shortage is the latest in a series of serious shortages of cancer medications and other drugs that have frustrated doctors and patients over the past year and a half.

Only a few days ago, cancer specialists had predicted they could run out of methotrexate by the end of next week, according to Dr. Michael Link, a pediatric oncologist who is president of the American Society of Clinical Oncology. The shortfall arose when 1 of the 4 U.S. makers of methotrexate, Ohio-based Ben Venue Laboratories, shut down production late last year because of “manufacturing and quality concerns,” FDA spokeswoman Shelly Burgess said.

Read the full story at: http://tinyurl.com/6vbfmqd

Additional media coverage available at Kaiser Health News: http://tinyurl.com/7d5396h

Sources: Gannett News Service, Chicago Sun-Times, Kaiser Health News

Related Videos
Amitkumar Mehta, MD, MBA
dr amy laughlin
dr kathi mooney
dr saira jan
dr saira jan
Ted Okon, MBA, Community Oncology Alliance
Miriam J. Atkins, MD, FACP, Community Oncology Alliance/AO Multispecialty Clinic
Lalan Wilfongd, MD, US Oncology Network
Alma Habib, MD
Related Content
© 2023 MJH Life Sciences
AJMC®
All rights reserved.